Upload
nguyenminh
View
212
Download
0
Embed Size (px)
Citation preview
wwwecioorg
C RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
POCKET GUIDE
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
MO
NS
UN
TU
EW
ED
2
17
23
29
35
37
54
Sunday ndash Scientific Programme
Monday ndash Scientific Programme
Tuesday ndash Scientific Programme
Wednesday ndash Scientific Programme
2 Important Addresses
3 Committees
4 General Information
10 Honorary Lecture
12 Hands-on Workshops
Corporate Activities
39 Satellite Symposia
51 Hands-on Workshop Sponsors
Exhibitors and Sponsors
54 Sponsors
57 Technical Exhibition Alphabetical List
59 Technical Exhibition Numerical List
61 Technical Exhibitors Guide
Important Addresses
Congress Venue
The Convention Centre Dublin
Spencer Dock
Dublin 1
Ireland
Organising Secretariat
CIRSE Central Office
Neutorgasse 9
1010 Vienna
Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-Mail infocirseorg
Web wwwecioorg
C RSE
2 ECIO ndash European Conference on Interventional Oncology
Important Addresses Committees
Committees
Advisory Board
Andreas Adam (UK)
Thierry de Baegravere (FR)
Johannes Lammer (AT)
Riccardo Lencioni (US)
Jan H Peregrin (CZ)
Jim A Reekers (NL)
Scientific Programme Committee
Thomas K Helmberger (DE) Chairperson
Afshin Gangi (FR) Deputy Chairperson
Jose I Bilbao (ES)
Christoph A Binkert (CH)
Elias Brountzos (GR)
Thierry de Baegravere (FR)
Alban Denys (CH)
Jean-Franccedilois H Geschwind (US)
Bernd Hamm (DE)
Michael J Lee (IE)
Katerina Malagari (GR)
Philippe L Pereira (DE)
Local Host Committee
Michael J Lee (Dublin) Chairperson
Colin Cantwell (Dublin)
Tony Geoghegan (Dublin)
Peter Kennedy (Belfast)
Gerard J OSullivan (Galway)
Anthony G Ryan (Waterford City)
Mark Ryan (Dublin)
William Torreggiani (Dublin)
David Tuite (Cork)
The European Conference on Interventional Oncology
is organised by CIRSE (Cardiovascular and Interventional
Radiological Society of Europe)
The official congress website is wwwecioorg
To contact the CIRSE Central Office or members of the
committee please write to infocirseorg
3
Cardiovascular and Interventional Radiological Society of Europe
4 ECIO ndash European Conference on Interventional Oncology
General Information from A to Z
App
Let the CIRSE app take care of your congress planning New-
comers please download the CIRSE society app which is
available for iPhone iPad and Android (wwwcirseorgapp)
and install the ECIO 2016 event If the CIRSE society app is
already on your smartphone please just install the ECIO 2016
event and have the best toolkit to plan your personal con -
gress programme evaluate sessions browse the exhibition
take part in votings and submit questions to the moderator
in selected sessions
Badges
Your personalised badge is your admission card to the
congress For organisational and security reasons badges
must be worn at the congress venue at all times A lanyard
will be given to you with the congress bag Identity checks
in the congress centre may occur at any time In case of loss
a replacement badge will be provided for an administrative
charge of euro80
Certificate of Attendance
To obtain your certificate of attendance you can choose one
of the following options
Print your certificate onsite at the congress
From 1000 on Tuesday April 19 you can use one of the
dedicated workstations in the registration area to print your
certificate All you need is your congress badge
Print your certificate at home
After the congress you will be able to print your certificate
of attendance at wwwecioorg All you will need is your last
name and badge number Alternatively you could log into
your personal CIRSE account at wwwcirseorg with your per-
sonal log-in details
C RSE
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
MO
NS
UN
TU
EW
ED
2
17
23
29
35
37
54
Sunday ndash Scientific Programme
Monday ndash Scientific Programme
Tuesday ndash Scientific Programme
Wednesday ndash Scientific Programme
2 Important Addresses
3 Committees
4 General Information
10 Honorary Lecture
12 Hands-on Workshops
Corporate Activities
39 Satellite Symposia
51 Hands-on Workshop Sponsors
Exhibitors and Sponsors
54 Sponsors
57 Technical Exhibition Alphabetical List
59 Technical Exhibition Numerical List
61 Technical Exhibitors Guide
Important Addresses
Congress Venue
The Convention Centre Dublin
Spencer Dock
Dublin 1
Ireland
Organising Secretariat
CIRSE Central Office
Neutorgasse 9
1010 Vienna
Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-Mail infocirseorg
Web wwwecioorg
C RSE
2 ECIO ndash European Conference on Interventional Oncology
Important Addresses Committees
Committees
Advisory Board
Andreas Adam (UK)
Thierry de Baegravere (FR)
Johannes Lammer (AT)
Riccardo Lencioni (US)
Jan H Peregrin (CZ)
Jim A Reekers (NL)
Scientific Programme Committee
Thomas K Helmberger (DE) Chairperson
Afshin Gangi (FR) Deputy Chairperson
Jose I Bilbao (ES)
Christoph A Binkert (CH)
Elias Brountzos (GR)
Thierry de Baegravere (FR)
Alban Denys (CH)
Jean-Franccedilois H Geschwind (US)
Bernd Hamm (DE)
Michael J Lee (IE)
Katerina Malagari (GR)
Philippe L Pereira (DE)
Local Host Committee
Michael J Lee (Dublin) Chairperson
Colin Cantwell (Dublin)
Tony Geoghegan (Dublin)
Peter Kennedy (Belfast)
Gerard J OSullivan (Galway)
Anthony G Ryan (Waterford City)
Mark Ryan (Dublin)
William Torreggiani (Dublin)
David Tuite (Cork)
The European Conference on Interventional Oncology
is organised by CIRSE (Cardiovascular and Interventional
Radiological Society of Europe)
The official congress website is wwwecioorg
To contact the CIRSE Central Office or members of the
committee please write to infocirseorg
3
Cardiovascular and Interventional Radiological Society of Europe
4 ECIO ndash European Conference on Interventional Oncology
General Information from A to Z
App
Let the CIRSE app take care of your congress planning New-
comers please download the CIRSE society app which is
available for iPhone iPad and Android (wwwcirseorgapp)
and install the ECIO 2016 event If the CIRSE society app is
already on your smartphone please just install the ECIO 2016
event and have the best toolkit to plan your personal con -
gress programme evaluate sessions browse the exhibition
take part in votings and submit questions to the moderator
in selected sessions
Badges
Your personalised badge is your admission card to the
congress For organisational and security reasons badges
must be worn at the congress venue at all times A lanyard
will be given to you with the congress bag Identity checks
in the congress centre may occur at any time In case of loss
a replacement badge will be provided for an administrative
charge of euro80
Certificate of Attendance
To obtain your certificate of attendance you can choose one
of the following options
Print your certificate onsite at the congress
From 1000 on Tuesday April 19 you can use one of the
dedicated workstations in the registration area to print your
certificate All you need is your congress badge
Print your certificate at home
After the congress you will be able to print your certificate
of attendance at wwwecioorg All you will need is your last
name and badge number Alternatively you could log into
your personal CIRSE account at wwwcirseorg with your per-
sonal log-in details
C RSE
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Important Addresses
Congress Venue
The Convention Centre Dublin
Spencer Dock
Dublin 1
Ireland
Organising Secretariat
CIRSE Central Office
Neutorgasse 9
1010 Vienna
Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-Mail infocirseorg
Web wwwecioorg
C RSE
2 ECIO ndash European Conference on Interventional Oncology
Important Addresses Committees
Committees
Advisory Board
Andreas Adam (UK)
Thierry de Baegravere (FR)
Johannes Lammer (AT)
Riccardo Lencioni (US)
Jan H Peregrin (CZ)
Jim A Reekers (NL)
Scientific Programme Committee
Thomas K Helmberger (DE) Chairperson
Afshin Gangi (FR) Deputy Chairperson
Jose I Bilbao (ES)
Christoph A Binkert (CH)
Elias Brountzos (GR)
Thierry de Baegravere (FR)
Alban Denys (CH)
Jean-Franccedilois H Geschwind (US)
Bernd Hamm (DE)
Michael J Lee (IE)
Katerina Malagari (GR)
Philippe L Pereira (DE)
Local Host Committee
Michael J Lee (Dublin) Chairperson
Colin Cantwell (Dublin)
Tony Geoghegan (Dublin)
Peter Kennedy (Belfast)
Gerard J OSullivan (Galway)
Anthony G Ryan (Waterford City)
Mark Ryan (Dublin)
William Torreggiani (Dublin)
David Tuite (Cork)
The European Conference on Interventional Oncology
is organised by CIRSE (Cardiovascular and Interventional
Radiological Society of Europe)
The official congress website is wwwecioorg
To contact the CIRSE Central Office or members of the
committee please write to infocirseorg
3
Cardiovascular and Interventional Radiological Society of Europe
4 ECIO ndash European Conference on Interventional Oncology
General Information from A to Z
App
Let the CIRSE app take care of your congress planning New-
comers please download the CIRSE society app which is
available for iPhone iPad and Android (wwwcirseorgapp)
and install the ECIO 2016 event If the CIRSE society app is
already on your smartphone please just install the ECIO 2016
event and have the best toolkit to plan your personal con -
gress programme evaluate sessions browse the exhibition
take part in votings and submit questions to the moderator
in selected sessions
Badges
Your personalised badge is your admission card to the
congress For organisational and security reasons badges
must be worn at the congress venue at all times A lanyard
will be given to you with the congress bag Identity checks
in the congress centre may occur at any time In case of loss
a replacement badge will be provided for an administrative
charge of euro80
Certificate of Attendance
To obtain your certificate of attendance you can choose one
of the following options
Print your certificate onsite at the congress
From 1000 on Tuesday April 19 you can use one of the
dedicated workstations in the registration area to print your
certificate All you need is your congress badge
Print your certificate at home
After the congress you will be able to print your certificate
of attendance at wwwecioorg All you will need is your last
name and badge number Alternatively you could log into
your personal CIRSE account at wwwcirseorg with your per-
sonal log-in details
C RSE
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Important Addresses Committees
Committees
Advisory Board
Andreas Adam (UK)
Thierry de Baegravere (FR)
Johannes Lammer (AT)
Riccardo Lencioni (US)
Jan H Peregrin (CZ)
Jim A Reekers (NL)
Scientific Programme Committee
Thomas K Helmberger (DE) Chairperson
Afshin Gangi (FR) Deputy Chairperson
Jose I Bilbao (ES)
Christoph A Binkert (CH)
Elias Brountzos (GR)
Thierry de Baegravere (FR)
Alban Denys (CH)
Jean-Franccedilois H Geschwind (US)
Bernd Hamm (DE)
Michael J Lee (IE)
Katerina Malagari (GR)
Philippe L Pereira (DE)
Local Host Committee
Michael J Lee (Dublin) Chairperson
Colin Cantwell (Dublin)
Tony Geoghegan (Dublin)
Peter Kennedy (Belfast)
Gerard J OSullivan (Galway)
Anthony G Ryan (Waterford City)
Mark Ryan (Dublin)
William Torreggiani (Dublin)
David Tuite (Cork)
The European Conference on Interventional Oncology
is organised by CIRSE (Cardiovascular and Interventional
Radiological Society of Europe)
The official congress website is wwwecioorg
To contact the CIRSE Central Office or members of the
committee please write to infocirseorg
3
Cardiovascular and Interventional Radiological Society of Europe
4 ECIO ndash European Conference on Interventional Oncology
General Information from A to Z
App
Let the CIRSE app take care of your congress planning New-
comers please download the CIRSE society app which is
available for iPhone iPad and Android (wwwcirseorgapp)
and install the ECIO 2016 event If the CIRSE society app is
already on your smartphone please just install the ECIO 2016
event and have the best toolkit to plan your personal con -
gress programme evaluate sessions browse the exhibition
take part in votings and submit questions to the moderator
in selected sessions
Badges
Your personalised badge is your admission card to the
congress For organisational and security reasons badges
must be worn at the congress venue at all times A lanyard
will be given to you with the congress bag Identity checks
in the congress centre may occur at any time In case of loss
a replacement badge will be provided for an administrative
charge of euro80
Certificate of Attendance
To obtain your certificate of attendance you can choose one
of the following options
Print your certificate onsite at the congress
From 1000 on Tuesday April 19 you can use one of the
dedicated workstations in the registration area to print your
certificate All you need is your congress badge
Print your certificate at home
After the congress you will be able to print your certificate
of attendance at wwwecioorg All you will need is your last
name and badge number Alternatively you could log into
your personal CIRSE account at wwwcirseorg with your per-
sonal log-in details
C RSE
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
4 ECIO ndash European Conference on Interventional Oncology
General Information from A to Z
App
Let the CIRSE app take care of your congress planning New-
comers please download the CIRSE society app which is
available for iPhone iPad and Android (wwwcirseorgapp)
and install the ECIO 2016 event If the CIRSE society app is
already on your smartphone please just install the ECIO 2016
event and have the best toolkit to plan your personal con -
gress programme evaluate sessions browse the exhibition
take part in votings and submit questions to the moderator
in selected sessions
Badges
Your personalised badge is your admission card to the
congress For organisational and security reasons badges
must be worn at the congress venue at all times A lanyard
will be given to you with the congress bag Identity checks
in the congress centre may occur at any time In case of loss
a replacement badge will be provided for an administrative
charge of euro80
Certificate of Attendance
To obtain your certificate of attendance you can choose one
of the following options
Print your certificate onsite at the congress
From 1000 on Tuesday April 19 you can use one of the
dedicated workstations in the registration area to print your
certificate All you need is your congress badge
Print your certificate at home
After the congress you will be able to print your certificate
of attendance at wwwecioorg All you will need is your last
name and badge number Alternatively you could log into
your personal CIRSE account at wwwcirseorg with your per-
sonal log-in details
C RSE
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
5
Cardiovascular and Interventional Radiological Society of Europe
General Information 5
CME Credit Allowance
CIRSE is accredited by the European Accreditation Council
for Continuing Medical Education (EACCME) to provide the
following CME activity for medical specialists The EACCME
is an institution of the European Union of Medical Specialists
(UEMS) wwwuemsnet
ECIO 2016 is designated for up to 21 hours of European
external CME credits Each medical specialist should claim
only those hours of credit that heshe actually spent in the
educational activity
Through an agreement between the European Union of
Medical Specialists and the American Medical Association
physicians may convert EACCME credits to an equivalent
number of AMA PRA Category 1 Creditstrade Information on the
process to convert EACCME credit to AMA credit can be found
at wwwama-assnorggointernationalcme
Live educational activities occurring outside of Canada
recognised by the UEMS-EACCME for ECMEC credits are
deemed to be Accredited Group Learning Activities (Section 1)
as defined by the Maintenance of Certification Program of The
Royal College of Physicians and Surgeons of Canada
Coffee Breaks Snacks amp Meals
During the breaks refreshments can be purchased at the
Liffey Bar located on the first floor foyer
The Liffey Bar opens at 0900
A complimentary lunch buffet and afternoon refreshments
provided by the sponsors of the lunch symposia will be avail-
able in the exhibition area Lunch will be from 1200-1300
and the afternoon break will be from 1630-1700
Disclaimer
CIRSE cannot accept any liability for the acts of the suppliers
to this meeting or the attendeesrsquo safety while travelling to
or from the congress All participants are strongly advised to
carry adequate travel and health insurance as CIRSE cannot
accept liability for accidents or injuries that may occur
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
C RSE
6 ECIO ndash European Conference on Interventional Oncology
Disclosures
For financial disclosures and conflict of interest statements
please refer to wwwecioorg
ESIRonline ndash wwwesirorg
ESIRonline is the largest online presentation database for
interventional radiology featuring slides and webcasts from
CIRSE meetings since 2006 With a large section covering
oncology topics ESIRonline is the ideal tool for your research
and educational needs Presentations recorded at ECIO 2016
will be integrated shortly after the meeting Access to all
content is free for CIRSE members and year-round access is
included with an ECIO 2016 registration
Evaluation
To complete the session evaluation and obtain credits for
your attendance at ECIO 2016 sessions please use the online
evaluation system accessible through the CIRSE mobile app
(please see page 4) and at httpsevalwebgescomecio2016
Internet
A free wireless service is available to all delegates throughout
the congress centre
Network ECIO2016
Password ecio2016
Mobile Phones
Please do not forget to turn your mobile phone to silent
mode during the sessions
Recording and Photographs
Please note that any form of recording filming or photo-
graphing of presentation material during the sessions is
strictly forbidden Subject to the authorsrsquo consent all pres-
entation material will be made available online on CIRSErsquos
educational platform ESIRonline
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
General Information 7
Registration Desk ndash Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1800
Monday April 18 0730-1800
Tuesday April 19 0730-1800
Wednesday April 20 0800-1100
Smoking
The ECIO Annual Meeting is a non-smoking congress
Smoking is permitted outside the congress centre only
Speaker Centre
The Speaker Centre is located on the first floor of the
congress centre in Liffey Meeting Room 2a Please note that
only digital material will be allowed for oral presentations
All material must be in English and provided on a CD-ROM
DVD-ROM or USB flash drive (which is preferred) to be placed
on the central server onsite All presentation files must be
uploaded at least 3 hours prior to the beginning of the
corresponding session
Computers connected to the local server allowing access
to the speakersrsquo presentations are available in every lecture
room These computers are equipped with Microsoft
Windows 7 Professional and Microsoft Office 2013 Pro-
fessional Please note that speakers are not allowed to use
their own laptops for their presentations
Opening Hours
Saturday April 16 1600-1800
Sunday April 17 0730-1900
Monday April 18 0730-1900
Tuesday April 19 0730-1900
Wednesday April 20 0800-1200
Sponsors and Exhibitors
Please find a floor plan of the exhibition on the inside of the
front cover and a detailed list of all exhibitors and sponsors
on pages 54ndash83
Cardiovascular and Interventional Radiological Society of Europe
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
8
Opening Hours
Sunday April 17 0930-1730
Monday April 18 0930-1730
Tuesday April 19 0930-1730
Wednesday April 20 0930-1230
Tourist Information and Hospitality Desk
For information regarding restaurants and excursions please
refer to the desk of our official travel partner Kuoni located in
the registration area Kuoni will be pleased to help you with
all matters related to your stay in Dublin
ECIO ndash European Conference on Interventional Oncology
C RSE
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
9General Information
Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe
G E T YO U R E C I O P R O G R A M M E
VIA THE CIRSE SOCIETY APP
I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N
Make the most of your time at ECIO 2016
bull participate in e-voting polls
bull evaluate sessions (see p6)
bull send questions to the moderators
bull build your personal schedule
bull navigate the exhibition
bull and much more
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Leaders in Oncologic Interventions
Bruno SangroHonorary Lecturer
Prof Bruno Sangro attained his medical degree from the
Universidad Complutense in Madrid in 1983 and trained
in medical oncology at the Hospital Cliacutenico de San Carlos
before moving to Pamplona After completing a residency
programme in internal medicine he joined the Liver Unit
at Cliacutenica Universidad de Navarra where he has spent the
remainder of his career He is now Director of the Liver Unit
and Co-Director of the HPB Oncology Area He has a strong
interest in teaching pre- and post-graduate medical students
and is now a full professor in the School of Medicine
Over the years his interest in medical research has focused
on therapeutic innovation in the field of liver diseases ndash most
specifically primary and secondary liver cancer Since earning
his PhD he has served as principal investigator of the
Therapeutic Strategies in Liver Disease group in the National
Network on Research in Hepatology and Gastroenterology
(2003-2006) and has worked as senior researcher in the
Group of Experimental Hepatology in the Spanish Network
for Biomedical Research on Hepatic and Digestive Diseases
(CIBERehd) since 2007 where he is now the principal
investigator He has also served on the governing board of
the Division of Hepatology and Gene Therapy in the Center
for Applied Medical Research at Pamplona and is now
Director of the Area of Digestive and Metabolic Diseases in
the Navarra Institute of Health Research
Under his collaboration or direction the Liver Unit and
the HPB Oncology Area at Cliacutenica Universidad de Navarra
have pioneered several approaches in the treatment of
liver tumours These include the use of expanded criteria to
indicate liver transplantation in patients with hepatocellular
carcinoma The close collaboration sustained for decades
with Prof Joseacute Ignacio Bilbao has resulted in relevant
contributions to the study of mechanism of action devices
procedures and indications for the intra-arterial treatment of
hepatocellular carcinoma and other primary and secondary
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
liver tumours including intra-arterial infusion chemotherapy
bland embolisation chemoembolisation and most recently
radioembolisation
The team at Cliacutenica Universitaria was the first to explore
locoregional gene therapy of liver cancer in humans by
percutaneous injection of viral vectors and developed
procedures to monitor transgene expression in vivo with
PET radiotracers In more recent years they have pioneered
the field of immunotherapy of liver cancer using different
approaches that include peptide and cell vaccination and
immune checkpoint inhibition The translational nature of
all these approaches is illustrated by the implementation of
several clinical trials exploring first-in-human and first-in-
disease applications of new agents for the treatment of liver
cancer and other liver diseases
Prof Sangro is a member of a number of national and inter-
national medical societies has served on the International
Committee of the American Society for Gene Therapy and
currently serves on the Governing Board of the International
Liver Cancer Association
Honorary Lecture
Intra-arterial treatment of hepatocellular
carcinoma at the dawn of systemic therapy
Monday April 18 1030-1130
11
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Hands-on Workshops
Image-guided tumour ablation
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of L Crocetti
This series of four stand-alone hands-on workshops will give
you the opportunity to participate in interactive sessions
targeting different organs (liver lung kidney and beyond)
In each leading interventional oncologists with many years
of experience will present cases in an informal interactive
setting allowing for questions and discussion A range of
different ablation devices (amongst others RFA cryotherapy
and microwave ablation) and some image-guidance tech-
nology will be available to the participants during the
sessions for ex-vivo demonstrations
Learning objectives
bull To learn how to handle different energy sources and the
respective equipment for tumour ablation
bull To obtain a good understanding of the range of available
ablation techniques and their proper clinical application
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal com-
bination of therapies
bull To understand the main reported complications of ablation
and the basics of preventing and managing them
bull To learn tips and tricks through the use of clinical cases
bull To learn about the indications for other medical and
surgical treatments generally
12 ECIO ndash European Conference on Interventional Oncology
C RSE
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Hands-on Workshops
Cardiovascular and Interventional Radiological Society of Europe
13
TA-HoW 1 Sunday April 17
Liver 1030-1200
Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)
M Ryan (DublinIE)
TA-HoW 2 Sunday April 17
Beyond the mainstream 1500-1630
thyroid prostate lymphnodes
Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
TA-HoW 3 Monday April 18
Lung 1030-1200
Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
TA-HoW 4 Monday April 18
Kidney 1500-1630
Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)
CM Sommer (HeidelbergDE)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshops If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshops please refer to page 51
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
14
Supportive procedures
Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)
Image courtesy of TK Helmberger
This hands-on workshop will give you the opportunity to
participate in interactive case presentations on supportive
therapies in cancer patients Leading interventional radio-
logists will present a number of cases in an informal inter-
active setting allowing for questions and discussion A range
of supportive devices (including devices for the management
of ascites and pleural effusion ports and central lines) will be
available to the participants during the session for ex-vivo
demonstrations
Learning objectives
bull To learn how to handle the different devices and
techniques available for supportive therapies
bull To obtain a good understanding of the range of available
techniques used to improve quality of life in patients with
advanced disease
bull To learn what factors are predictive of success and failure
in order to determine the best indication and optimal
combination of therapies
bull To learn tips and tricks through the use of clinical cases
bull To learn generally about the indications for other medical
and surgical palliative treatment options
ECIO ndash European Conference on Interventional Oncology
C RSE
NEW
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
15Hands-on Workshops
SP-HoW 1 Tuesday April 19
1030-1200
Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
Location
HoW Room (Liffey Meeting Room 1)
Please note that pre-registration was necessary for the hands-on
workshop If you have not pre-registered but are interested in
participating please arrive at the workshop room well in advance
to check availability
For an overview of the industry partners supporting the hands-on
workshop please refer to page 51
Cardiovascular and Interventional Radiological Society of Europe
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Special preparation courses for the EBIR
European Board of Interventional Radiology
co CIRSE
Neutorgasse 9 1010 Vienna Austria
ebircirseorg
wwwcirseorgebir
C RSE
The EBIR is a highly valuable qualification
in interventional radiology based on the
European Curriculum and Syllabus for IR
Sessions especially suited for EBIR preparation
are highlighted in the ECIO 2016 Scientific
Programme (pages 17-36)
The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016
Sign up to certify your expertise
European Board of Interventional Radiology
EB I R
For application deadlines and detailed information
please visit our website at wwwcirseorgebir
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Scientific Programme
SU
N
Sunday April 17
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 101 Current treatment strategies in colorectal
hepatic metastases
Moderators A Gangi (StrasbourgFR)
MJ Lee (DublinIE)
1011 From first line to maintenance
G Folprecht (DresdenDE)
1012 The rationale for resection of small liver metastases
T Gruenberger (ViennaAT)
1013 Invited scientific paper What are the factors
associated with an increased risk of local
recurrence after radiofrequency ablation or
surgical metastasectomy
N Vietti-Violi PE Bize R Duran N Demartines
N Halkic J-F Knebel A Denys LausanneCH
1014 The rationale for local ablation of small liver
metastases
PL Pereira (HeilbronnDE)
1015 The rationale of radioembolisation of colorectal
liver metastases
C Farrelly (DublinIE)
1016 Summary statement by the moderators
17
recommended for EBIR preparatione-voting
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
C RSE
SU
N
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 201 Colorectal hepatic metastases ndash clinical practice
Moderators RGH Beets-Tan (AmsterdamNL)
R Lencioni (Miami FLUS)
2011 The challenging resection ndash where IR can support
surgery
A Denys (LausanneCH)
2012 Percutaneous ablation ndash influence of device
CT Sofocleous (New York NYUS)
2013 Transarterial chemotherapy regimens
T de Baegravere (VillejuifFR)
2014 Limits of systemic therapies ndash individualised local
approaches
B George (Milwaukee WIUS)
2015 Radioembolisation in the palliative setting
R Seidensticker (MagdeburgDE)
1030-1200 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 202 Image guidance for IO
Moderators R Bale (InnsbruckAT)
L Martiacute-Bonmatiacute (ValenciaES)
2021 Ultrasound fusion imaging
L Solbiati (RozzanoIT)
2022 Cone-beam CT for vascular intervention
J-FH Geschwind (New Haven CTUS)
2023 Cone-beam CT for non-vascular intervention
MJL van Strijen (NieuwegeinNL)
2024 Combined angio and CT
PE Bize (LausanneCH)
2025 Stereotactic navigation and robotic
R Bale (InnsbruckAT)
2026 PET-CT and MRI ndash future trends
A Gangi (StrasbourgFR)
18 ECIO ndash European Conference on Interventional Oncology
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
SU
N
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 1 Image-guided tumour ablation ndash Liver
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors AH Mahnken (MarburgDE)
F Orsi (MilanIT) M Ryan (DublinIE)
1300-1430 Main Auditorium (The Liffey A)
SY 301 Satellite Symposium
For the detailed programme
please refer to page 39
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 401 Colorectal hepatic metastases
Co-ordinator JI Bilbao (PamplonaES)
Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)
L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)
CT Sofocleous (New York NYUS)
Scientific Programme 19
recommended for EBIR preparatione-voting
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
SU
N
20 ECIO ndash European Conference on Interventional Oncology
C RSE
1500-1630 Auditorium 2 (Liffey Hall 2)
Technical Focus Session
TF 402 Recent developments
Moderators T de Baegravere (VillejuifFR)
RA Morgan (LondonUK)
4021 Drug-eluting particles ndash what can be loaded
SB White (Milwaukee WIUS)
4022 Thermal ablation ndash whats in the labs
F Orsi (MilanIT)
4023 Nanoparticles and nanodrugs ndash are we there yet
N Goldberg (JerusalemIL)
4024 Invited scientific paper Computed tomography
and magnetic resonance imaging characteristics
of novel radiopaque Yttrium-Strontium-Galliumndash
Silicate oxide glass microspheres potential materials
for radioembolisation
X Zhang S Kehoe C Davis E Tonkopi D Boyd
C Bowen R Abraham K Brewer Halifax NSCA
4025 Invited scientific paper Confocal laser endo-
microscopy for microscopic characterization of
kidney and liver tumours during ongoing in vivo
percutaneous biopsies and ex vivo cryoablation
preliminary results
A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1
PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR
4026 Local delivery of immunotherapy
MHMGM den Brok (NijmegenNL)
4027 Radioembolisation beyond Y-90
MGEH Lam (UtrechtNL)
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
SU
N
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 2 Image-guided tumour ablation ndash Beyond the
mainstream thyroid prostate lymphnodes
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors JH Baek (SeoulKR)
JJ Fuumltterer (NijmegenNL)
EM Walser (Galveston TXUS)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 501 Follow-up in colorectal cancer patients
are we missing something
Moderators T de Baegravere (VillejuifFR)
T Ruers (AmsterdamNL)
5011 Follow-up according to the guidelines
RGH Beets-Tan (AmsterdamNL)
5012 Do recent guidelines meet the clinical reality
PL Pereira (HeilbronnDE)
5013 Whats the key issue marker vs morphology
vs clinics
L Martiacute-Bonmatiacute (ValenciaES)
5014 Multiparametric imaging for follow-up ndash pushing
the boundaries
S Gourtsoyianni (LondonUK)
5015 Proposal for a rational follow-up regimen
R Lencioni (Miami FLUS)
21Scientific Programme
recommended for EBIR preparatione-voting
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
22 ECIO ndash European Conference on Interventional Oncology
C RSE
SU
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 502 Clinical management of the cancer patient
Moderators C Ayuso (BarcelonaES)
AG Ryan (Waterford CityIE)
5021 Who should see the patient What are the needs
for an IO practice
A Adam (LondonUK)
5022 Coagulation problems and solutions
F Niacute Aacuteinle (DublinIE)
5023 Prevention and management of infection
GA Maleux (LeuvenBE)
5024 Adjuvant interventional pain management
A Vari (RomeIT)
5025 Follow-up when and how
I Bargellini (PisaIT)
1830-1915 Main Auditorium (The Liffey A)
SY 601 Satellite Symposium
For the detailed programme
please refer to page 39
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
23
MO
N
Scientific Programme
0745-0815 Main Auditorium (The Liffey A)
SY 701 Satellite Symposium
For the detailed programme
please refer to page 41
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 801 Lung metastases
Moderators L Crocetti (PisaIT)
J Palussiegravere (BordeauxFR)
8011 Indications for local therapy ndash the oncologists view
J-E Kurtz (StrasbourgFR)
8012 Surgical resection ndash current status
M Shackcloth (LiverpoolUK)
8013 Invited scientific paper Radiofrequency abla-
tion versus surgery for the treatment of lung
metastases a comparative study
L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1
O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2
F Deschamps1 1VillejuifFR 2Plessis RobinsonFR
8014 Radiation therapy ndash current status
R Timmerman (Dallas TXUS)
8015 Percutaneous ablation ndash current status
T de Baegravere (VillejuifFR)
8016 How to evaluate the success and recurrence
after resection SBRT and ablation
RD Suh (Los Angeles CAUS)
Monday April 18
recommended for EBIR preparatione-voting
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
MO
N
24 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 802 Immunotherapy and local treatment
Moderators N Goldberg (JerusalemIL)
PL Pereira (HeilbronnDE)
8021 Immunomodulation for cancer treatment
new kid on the block
M Fuchs (MunichDE)
8022 Hepatocellular carcinoma from an immunological
perspective
BJ Wood (Bethesda MDUS)
8023 Rationale for local delivery of immunomodulating
agents and ongoing clinical trials
L Tselikas (VillejuifFR)
8024 More than just tumour destruction immunomo-
dulation via thermal ablation of cancer
C Gouttefangeas (TuebingenDE)
8025 Immunomodulation and radioembolisation
J Ricke (MagdeburgDE)
8026 Panel discussion
1030-1130 Main Auditorium (The Liffey A)
HL 901 Honorary Lecture
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
Laudation JI Bilbao (PamplonaES)
9011 Intra-arterial treatment of hepatocellular carcinoma
at the dawn of systemic therapy
B Sangro (PamplonaES)
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
1130-1200 Main Auditorium (The Liffey A)
Paper Session
PS 902 The best IO papers of 2015
Moderators A-M Belli (LondonUK)
TK Helmberger (MunichDE)
9021 Irreversible electroporation (IRE) fails to demons-
trate efficacy in a prospective multicentre phase II
trial on lung malignancies the ALICE trial
J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2
K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR
9022 Radiofrequency ablation inflammatory changes
in the periablative zone can induce global organ
effects including liver regeneration
N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1
H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS
9023 Hepatic radiofrequency ablation-induced
stimulation of distant tumour growth is suppressed
by c-Met inhibition
M Ahmed1 G Kumar1 M Moussa1 Y Wang1
N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 3 Image-guided tumour ablation ndash Lung
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors P Kennedy (BelfastUK)
CT Sofocleous (New York NYUS)
RD Suh (Los Angeles CAUS)
1300-1345 Main Auditorium (The Liffey A)
SY 1001 Satellite Symposium
For the detailed programme
please refer to page 41
MO
N
25Scientific Programme
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
MO
N
26 ECIO ndash European Conference on Interventional Oncology
C RSE
1345-1430 Main Auditorium (The Liffey A)
SY 1002 Satellite Symposium
For the detailed programme
please refer to page 43
1500-1630 Main Auditorium (The Liffey A)
Multidisciplinary Tumour Board
MTB 1101 Lung tumours
Co-ordinator A Gillams (LondonUK)
Panellists P Kennedy (BelfastUK) J Palussiegravere
(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth
(LiverpoolUK) RD Suh (Los Angeles CAUS)
1500-1630 Auditorium 2 (Liffey Hall 2)
Joint Session
JS 1102 Meeting the diverse challenges of
interventional oncology
Joint session with the Indian Society of
Vascular and Interventional Radiology (ISVIR)
Moderators A-M Belli (LondonUK)
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11021 Current situation of interventional oncology in India
S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)
11022 Thermal ablation of lung tumours
A Kulkarni (MumbaiIN)
11023 Hepatobiliary interventions in liver transplant
SS Baijal (GurgaonIN)
11024 Selective ophthalmic arterial chemoinfusion for
retinoblastoma
SS Kulkarni (MumbaiIN)
11025 Indian registry data for interventions in the
management of hepatocellular carcinoma
S Gamanagatti (New DelhiIN)
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
27
1500-1630 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
TA-HoW 4 Image-guided tumour ablation ndash Kidney
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors DJ Breen (SouthamptonUK)
J-M Correas (ParisFR) CM Sommer (HeidelbergDE)
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1201 Kidney tumours
Moderators PE Bize (LausanneCH)
A Gangi (StrasbourgFR)
12011 Renal mass ndash from surveillance to treatment
M Staehler (MunichDE)
12012 Evidence-based nephron-sparing surgery
R Power (DublinIE)
12013 Invited scientific paper Systematic review and
meta-analysis of thermal ablation versus surgical
nephrectomy for small renal tumours
KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1
T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK
12014 Evidence-based ablation vs resection outcomes
DJ Breen (SouthamptonUK)
12015 Adjuvant intervention in non-resectable renal
tumours
G Carrafiello (VareseIT)
12016 Radioembolisation of renal tumours
WS Rilling (Milwaukee WIUS)
27Scientific Programme
MO
N
recommended for EBIR preparatione-voting
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
28 ECIO ndash European Conference on Interventional Oncology
C RSE
MO
N
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1202 Oncological basics
Moderators G Folprecht (DresdenDE)
LM Kenny (Brisbane QLDAU)
12021 From systemic therapy to an individualised
personalised and precision medicine
G Folprecht (DresdenDE)
12022 Phase I II III trials do you really know the
difference
S Faivre (LausanneCH)
12023 Definition of response and success in medical
oncology
OS Breathnach (DublinIE)
12024 Definition of response and success in IO
R Salem (Chicago ILUS)
12025 Best IO from ASCO
TK Helmberger (MunichDE)
12026 Panel discussion
1830-1915 Auditorium 2 (Liffey Hall 2)
SY 1301 Satellite Symposium
For the detailed programme
please refer to page 43
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
TU
E
29Scientific Programme
Tuesday April 19
0745-0815 Auditorium 2 (Liffey Hall 2)
SY 1401 Satellite Symposium
For the detailed programme
please refer to page 45
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1501 HCC ndash an update
Moderators J Lammer (ViennaAT)
B Sangro (PamplonaES)
15011 Current status of classifying HCC and tailoring
therapy ndash an update on staging
J-FH Geschwind (New Haven CTUS)
15012 Surgical perspectives on very early HCC and
early HCC
G Torzilli (MilanIT)
15013 IO perspectives on very early HCC and early HCC
C Cantwell (DublinIE)
15014 Chemoembolisation evidence for intermediate HCC
K Malagari (AthensGR)
15015 Therapies beyond BCLC guidelines
R Lencioni (Miami FLUS)
15016 Improving dosimetry in RE
E Garin (RennesFR)
recommended for EBIR preparatione-voting
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
TU
E
30 ECIO ndash European Conference on Interventional Oncology
C RSE
0830-1000 Auditorium 2 (Liffey Hall 2)
Video Learning Session
VL 1502 Lung kidney bone
Moderators DJ Breen (SouthamptonUK)
R-T Hoffmann (DresdenDE)
15021 Lung ablation
X Buy (BordeauxFR)
15022 Intra-arterial fiducial in lung tumours
PE Bize (LausanneCH)
15023 Kidney ablation
MP Fuumlrstner (KlagenfurtAT)
15024 Bone ablation
J Garnon (StrasbourgFR)
15025 Osteosynthesis
F Deschamps (VillejuifFR)
15026 Cementoplasty
DK Filippiadis (AthensGR)
1030-1200 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1601 MSK tumours
Moderators MR Callstrom (Rochester MNUS)
P Reimer (KarlsruheDE)
16011 Patient selection surgery andor IO
J-P Steib (StrasbourgFR)
16012 Can radiotherapists use the support of IR
R Timmerman (Dallas TXUS)
16013 Bone augmentation without ablation
DK Filippiadis (AthensGR)
16014 Ablative techniques for pain management
A Basile (CataniaIT)
16015 (Palliative) treatment options in soft tissue tumours
MR Callstrom (Rochester MNUS)
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
TU
E
31Scientific Programme
1030-1200 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1602 Complication management I
Moderators JI Bilbao (PamplonaES)
R Salem (Chicago ILUS)
16021 Liver thermal ablation
C Ayuso (BarcelonaES)
16022 Liver TACE
Y Arai (TokyoJP)
16023 Radioembolisation
R-T Hoffmann (DresdenDE)
16024 Bone consolidation
F Deschamps (VillejuifFR)
1030-1200 HoW Room (Liffey Meeting Room 1)
Hands-on Workshop
SP-HoW 1 Supportive procedures
Co-ordinators M Bezzi (RomeIT)
PL Pereira (HeilbronnDE)
Instructors B Gebauer (BerlinDE)
GJ Munneke (LondonUK)
KP van Lienden (AmsterdamNL)
1300-1345 Main Auditorium (The Liffey A)
SY 1701 Satellite Symposium
For the detailed programme
please refer to page 45
1345-1430 Main Auditorium (The Liffey A)
SY 1702 Satellite Symposium
For the detailed programme
please refer to page 47
recommended for EBIR preparatione-voting
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
32 ECIO ndash European Conference on Interventional Oncology
C RSE
TU
E
1500-1630 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1801 Cholangiocarcinoma
Moderators A Denys (LausanneCH)
W Jaschke (InnsbruckAT)
18011 Demographics epidemiology clinical presentation
D Gallagher (DublinIE)
18012 Surgery for central CC
O Farges (ClichyFR)
18013 Preparation for surgery ndash the IO perspective
A Denys (LausanneCH)
18014 Intraductal RFA in malignant biliary strictures
H-U Laasch (ManchesterUK)
18015 Transarterial chemotherapy
Y Arai (TokyoJP)
18016 Transarterial radioembolisation
B Peynircioglu (AnkaraTR)
1500-1630 Main Auditorium (The Liffey A)
Video Learning Session
VL 1802 Liver
Moderators I Bargellini (PisaIT)
K Malagari (AthensGR)
18021 Liver thermal ablation
L Crocetti (PisaIT)
18022 Liver chemoembolization
DW De Boo (AmsterdamNL)
18023 Liver radioembolisation
P Reimer (KarlsruheDE)
18024 Portal vein embolisation
KP van Lienden (AmsterdamNL)
18025 Hepatic vein occlusionembolisation
P Chevallier (NiceFR) B Guiu (MontpellierFR)
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
33
1700-1830 Auditorium 2 (Liffey Hall 2)
Clinical Focus Session
CF 1901 Quality assurance unnecessary bureaucracy
or essential tool
Moderators A Adam (LondonUK)
TK Helmberger (MunichDE)
19011 What is QA and why does it matter
K Ison (LondonUK)
19012 Radiation protection what it means for you
W Jaschke (InnsbruckAT)
19013 QA in surgical oncology
RA Audisio (St HelensUK)
19014 The CIRSE QA system for interventional oncology
an essential step to credibility in cancer care
LM Kenny (Brisbane QLDAU)
19015 DeGIR registry the national QA and qualification
programme (a 10-year experience)
P Reimer (KarlsruheDE)
19016 Panel discussion
TU
E
Scientific Programme
recommended for EBIR preparatione-voting
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
C RSE
34 ECIO ndash European Conference on Interventional Oncology
TU
E
1700-1830 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 1902 Complication management II
Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)
19021 Lung ablation
J Palussiegravere (BordeauxFR)
19022 Kidney ablation
DJ Breen (SouthamptonUK)
19023 MSK ablation
G Tsoumakidou (StrasbourgFR)
19024 Thyroid ablation
JH Baek (SeoulKR)
1830-1900 Main Auditorium (The Liffey A)
SY 2001 Satellite Symposium
For the detailed programme
please refer to page 47
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
35
Wednesday April 20
0830-1000 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2101 The new kids on the block
Moderators J-FH Geschwind (New Haven CTUS)
BJ Wood (Bethesda MDUS)
21011 IRE technique current status and developments
N Goldberg (JerusalemIL)
21012 HIFU technique current status and developments
I Mindjuk (DachauDE)
21013 Invited scientific paper
21014 Clinical status of HIFU
F Orsi (MilanIT)
21015 New devices for biopsy
J-Y Gaubert (MarseilleFR)
21016 Comparison of the different drug-eluting bead
platforms
J Namur (Jouy en JosasFR)
1000-1045 Main Auditorium (The Liffey A)
SY 2102 Satellite Symposium
For the detailed programme
please refer to page 49
WE
D
Scientific Programme
recommended for EBIR preparatione-voting
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
36 ECIO ndash European Conference on Interventional Oncology
WE
D
1115-1245 Main Auditorium (The Liffey A)
Clinical Focus Session
CF 2201 Neuroendocrine tumours
Moderators DJ Breen (SouthamptonUK)
B Gebauer (BerlinDE)
22011 Demographics epidemiology clinical presentation
M Eatock (BelfastUK)
22012 Systemic therapy
M Pavel (BerlinDE)
22013 Invited scientific paper Simultaneous (18)F-FDOPA
PETCT-guided biopsy and radiofrequency ablation
of recurrent neuroendocrine hepatic metastasis
further step toward a theranostic approach
A Imperiale J Garnon P Bachellier A Gangi
IJ Namer StrasbourgFR
22014 Nuclear medicine ndash diagnostics and treatment
F Forrer (St GallenCH)
22015 Transarterial therapy ndash chemoembolisation and
bland embolisation
B Guiu (MontpellierFR)
22016 Transarterial therapy ndash radioembolisation
JI Bilbao (PamplonaES)
C RSE
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
37
Cardiovascular and Interventional Radiological Society of EuropeC RSE
Seventh European Conference
on Interventional Oncology
April 17-20 2016
Dublin Ireland
ECIO 2016
Cardiovascular and Interventional Radiological Society of Europe
LEADERS IN ONCOLOGICINTERVENTIONS
CORPORATE ACTIVITIES amp EXHIBITION
Satellite Symposia
Hands-on Workshop Sponsors
Technical Exhibition
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
38 ECIO ndash European Conference on Interventional Oncology
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
39
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1300-1430 Main Auditorium (The Liffey A)
BTG
SY 301 See more Reach further Treat smarter
Individualising treatment in interventional
oncology
Moderators A Denys (LausanneCH)
TF Jakobs (MunichDE)
3011 Dosimetry from the clinical perspective why it
matters and how it works with TheraSpherereg
R Salem (Chicago ILUS)
3012 90Y microspheres dosimetry made simple
MGEH Lam (UtrechtNL)
3013 The evolution of TACE does novel technology mean
better outcomes
R Lencioni (Miami FLUS)
1830-1915 Main Auditorium (The Liffey A)
Boston Scientific
SY 601 Clinical updates and new insights on TANDEMTM
Microspheres in the treatment of HCC and mCRC
Moderators P Kennedy (BelfastUK)
GM Richter (StuttgartDE)
6011 Advanced and intensified microparticle chemo-
embolisation in liver tumours with curative potential
ndash breaking data from Miracle 1 trial
GM Richter (StuttgartDE)
6012 TANDEMTM loaded with Doxorubicin in the treatment
of HCC ndash pharmacokinetics and clinical results
K Malagari (AthensGR)
6013 Clinical results of a single center trial with Irinotecan
loaded TANDEMTM Microspheres in patients with
mCRC ndash the importance of optimal embolisation
technique
F Orsi (MilanIT)
Sunday April 17
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
40 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Cardiovascular and Interventional Radiological Society of Europe
41
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Main Auditorium (The Liffey A)
Toshiba Medical Systems Europe
SY 701 Innovating clinical pathways
Moderator B Guiu (MontpellierFR)
7011 New frontiers for interventional radiology under
ultrasound guidance combination of smart fusion
and smart navigation solutions
J Garnon (StrasbourgFR)
7012 INFINIX 4D CT Singapore General Hospital
experience
KH Tay (SingaporeSG)
1300-1345 Main Auditorium (The Liffey A)
Terumo Europe
SY 1001 IO armamentarium in the treatment algorithm
of mCRC
Moderators D Arnold (FreiburgDE)
PL Pereira (HeilbronnDE)
10011 Role of interventional oncology in CRC
ESMO guidelines
D Arnold (FreiburgDE)
10012 Case presentation
D Arnold (FreiburgDE)
10013 Intra-arterial infusion therapy D
T de Baegravere (VillejuifFR)
10014 Transarterial radioembolisation
A Denys (LausanneCH)
10015 DEB-TACE
PL Pereira (HeilbronnDE)
10016 Discussion
Conclusion and take home message
Monday April 18
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
42 ECIO ndash European Conference on Interventional Oncology
C RSE
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
43
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Medtronic
SY 1002 Innovations in thermal ablation
Moderator A Gillams (LondonUK)
10021 More than 1 year follow-up with Thermosphere
technology
T de Baegravere (VillejuifFR)
10022 Experiences of Thermosphere technology in renal
tumour ablation
A Magnusson (UppsalaSE)
10023 Liver complex cases with Thermosphere
technology
P Wiggermann (RegensburgDE)
1830-1915 Auditorium 2 (Liffey Hall 2)
Cocktail reception to be served in the room
Sirtex Medical Europe GmbH
SY 1301 Multi-modality treatment of colorectal liver
metastases (CLM) in 2016
Moderators TK Helmberger (MunichDE)
B Sangro (PamplonaES)
13011 The importance of the liver in metastatic
colorectal cancer (mCRC)
B Sangro (PamplonaES)
13012 Chemotherapy in mCRC
O Dubreuil (ParisFR)
13013 Loco-regional therapies for colorectal liver
metastases (CLM)
TK Helmberger (MunichDE)
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
44 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Cardiovascular and Interventional Radiological Society of Europe
45
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
0745-0815 Auditorium 2 (Liffey Hall 2)
PharmaCept GmbH
SY 1401 Studies based on DSM-TACE (EmboCeptreg S)
Moderator TJ Vogl (FrankfurtDE)
14011 DSM-TACE multicentre study in HCC treatment
placed in the Triveneto area northeastern Italy
S Dal Bello (Castelfranco VenetoIT)
14012 Introduction of the study concept FAST I ndash IV
TJ Vogl (FrankfurtDE)
1300-1345 Main Auditorium (The Liffey A)
Sirtex Medical Europe GmbH
SY 1701 Optimising the treatment of colorectal
liver metastases (CLM) with SIR-Spheresreg Y-90
resin microspheres
Moderators JI Bilbao (PamplonaES)
T de Baegravere (VillejuifFR)
17011 SIRFLOX study results
V Heinemann (MunichDE)
17012 Who are the best patients for SIR-Spheres Y-90
resin microspheres in CLM
P Boardman (OxfordUK)
17013 Panel discussion
Tuesday April 19
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
46 ECIO ndash European Conference on Interventional Oncology
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Cardiovascular and Interventional Radiological Society of Europe
47Satellite Symposia
1345-1430 Main Auditorium (The Liffey A)
Guerbet
SY 1702 cTACE principles clinical data amp guidelines
across the world
Moderator J-FH Geschwind (New Haven CTUS)
17021 cTACE fundamentals amp mechanism of action
J-FH Geschwind (New Haven CTUS)
17022 Unrivalled clinical data from Hepatology 2002
to Hepatology 2016
R Lencioni (Miami FLUS)
17023 Role of cTACE in guidelines of management of HCC
across the world
JM Llovet (BarcelonaES)
1830-1900 Main Auditorium (The Liffey A)
Merit Medical
SY 2001 Management of complex anatomy with
SwiftNINJAreg steerable microcatheter
Moderator Y Arai (TokyoJP)
20011 What is NINJA
Y Arai (TokyoJP)
20012 Initial experience with the SwiftNINJAreg in a high
volume interventional oncology centre
BC Meyer (HannoverDE)
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
48 ECIO ndash European Conference on Interventional Oncology
C RSE
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
49
Cardiovascular and Interventional Radiological Society of Europe
Satellite Symposia
1000-1045 Main Auditorium (The Liffey A)
Siemens Healthcare GmbH
SY 2102 Treatment efficacy and intra-procedural
therapy verification
21021 Flat-detector CT blood volume imaging in TACE
for HCC implications for treatment planning and
response
RL ODonohoe (DublinIE)
21022 Image-guided vertebroplasty with MIYABI
Angio-CT
F Clarenccedilon (ParisFR)
Wednesday April 20
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Hands-on Workshop Sponsors 51
The Image-guided tumour ablation hands-on workshop
is kindly supported by
bull AngioDynamics
bull Clinical Laserthermia Systems AB
bull Galil Medical
bull GE Healthcare
bull Medtronic
bull NeuWave Medical
bull Olympus Surgical Technologies Europe
bull RF Medical Co Ltd
bull Terumo Europe
The Supportive procedures hands-on workshop is kindly
supported by
bull Cook Medical
For detailed information on the hands-on workshops
please refer to pages 12-15
For further information about the industry partners please
refer to the Technical Exhibitors Guide (pages 61-83)
If you are interested in obtaining product information
outside of the hands-on workshop sessions please visit the
respective company booth in the exhibition area
Hands-on Workshop Sponsors
Cardiovascular and Interventional Radiological Society of Europe
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
52 ECIO ndash European Conference on Interventional Oncology
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
53
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Diamond Sponsors
54
DIAMOND
Booth 1
Booth 12
Booth 9
Booth 24
Booth 11
Booth 10
C RSE
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Platinum Sponsor
Boston Scientific International Booth 2
Gold Sponsors
Merit Medical Booth 22
PharmaCept Booth 18
STARmed Booth 4
Toshiba Medical Systems Europe Booth 23
Silver Sponsors
Clinical Laserthermia Systems Booth 13
DFINE Europe Booth 3
Galil Medical Booth 16
GE Healthcare Booth 8
NeuWave Medical Booth 17
RF Medical Booth 21
Surgical Specialties Booth 14
SILVERGOLD
PLATINUM
55
Platinum | Gold | Silver Sponsors
Cardiovascular and Interventional Radiological Society of Europe
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
56 ECIO ndash European Conference on Interventional Oncology
C RSE
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
Boston Scientific International 2
BTG 1
Clinical Laserthermia Systems 13
Delcath Systems 19
DFINE Europe 3
Endocare 6
Galil Medical 16
GE Healthcare 8
Guerbet 12
Hyprevention PTIB 7
Interventional News BIBA 4a
Medtronic 9
Merit Medical 22
Mint Medical 4b
Nanjing ECO Microwave System 20
NeuWave Medical 17
NUMA 15
PharmaCept 18
RF Medical 21
Siemens Healthcare 24
Sirtex Medical Europe 11
STARmed 4
Surefire Medical 5
Surgical Specialties 14
Terumo Europe 10
Toshiba Medical Systems Europe 23
Wisepress Medical Bookshop 25
Technical Exhibition (Alphabetical List)
57
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibition
Official Name Booth
BTG 1
Boston Scientific International 2
DFINE Europe 3
STARmed 4
Interventional News BIBA 4a
Mint Medical 4b
Surefire Medical 5
Endocare 6
Hyprevention PTIB 7
GE Healthcare 8
Medtronic 9
Terumo Europe 10
Sirtex Medical Europe 11
Guerbet 12
Clinical Laserthermia Systems 13
Surgical Specialties 14
NUMA 15
Galil Medical 16
NeuWave Medical 17
PharmaCept 18
Delcath Systems 19
Nanjing ECO Microwave System 20
RF Medical 21
Merit Medical 22
Toshiba Medical Systems Europe 23
Siemens Healthcare 24
Wisepress Medical Bookshop 25
Technical Exhibition (Numerical List)
59
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
C RSE
ECIO ndash European Conference on Interventional Oncology60
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
Technical Exhibitors Guide 61
Boston Scientific International SA 2
2 rue Reneacute Caudron CS 30206
78961 St Quentin en Yvelines CEDEX
FRANCE
Phone +33 139 30 97 00
wwwbostonscientificcom
Boston Scientific (NYSE BSX) is a worldwide developer manu-
facturer and marketer of medical devices with approximately
23000 employees and revenue of $7380 billion in 2014
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world As a global medical technology leader for more than 30
years we advance science for life by providing a broad range
of high performance solutions that address unmet patient
needs and reduce the cost of healthcare For more informa-
tion visit wwwbostonscientificeu and connect on Twitter
(bostonsci) and Facebook
BTG 1
Lakeview Riverside Way
Watchmoor Park Camberley
GU15 3YL Surrey
UNITED KINGDOM
Phone +44 1276 902 020
Fax +44 1252 732 777
wwwbtgplccom
At BTG we are focused on bringing to market innovative
pro ducts in specialist areas of medicine to better serve
doctors and patients Our growing portfolio of Interventional
Medicine products is designed to advance the treatment of
liver tumours advanced emphysema severe blood clots and
varicose veins while our Specialty Pharmaceuticals portfolio
offers antidotes that alleviate toxicity and treat rare con-
ditions Our products are primarily used in the treatment
of people with liver tumours and other hypervascularised
tumours as well as arteriovenous malformation The bead
products block arteries (embolisation) depriving tumours of
blood and nutrients Where approved drug-eluting beads
also deliver a chemotherapeutic drug directly to the tumour
Our radiotherapy product consists of millions of small glass
microspheres that deliver radiation directly to liver tumours
Technical Exhibitors Guide
PLATINUM
DIAMOND
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
62 ECIO ndash European Conference on Interventional Oncology
C RSE
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
63Technical Exhibitors Guide
Clincal Laserthermia Systems 13
Medicon Village Scheelevaumlgen 2
223 81 Lund
SWEDEN
Phone +46 46 15 21 00
wwwclinicallaserse
Clinical Laserthermia Systems (CLS) is a research-based
pro duct company which has developed the CE-marked
FDA-approved medical device TRANBERGCLS Cancer
Immunotherapy System and the imILTCLS treatment method
The product is fully developed and approved for use in
Europe and US to treat solid cancer tumors The equipment
consists of a mobile laser unit and sterile disposable patient
kits Primary tumors for which treatment with imILTCLS is
indicated may be found in the liver breast skin (malignant
melanoma) lung prostate kidney and pancreas The cancer is
treated with the heat produced by laser light which is guided
into the tumor via an optical fiber The system measures
and guides the heat in the tumor growth areas and causes
controlled local cell death The heat stimulates an immune-
mediated anti-cancer effect a kind of vaccination against
the treated cancer type Treatment can be provided as a minor
poly clinical procedure where the patient may be discharged
from the hospital after a brief period of observation imILTCLS
can be combined with immunostimulating drugs immediately
before during or after treatment During 2014-2016 CLS
is carrying out clinical studies in Europe CLS is based in
Medicon Village Lund Sweden
Delcath Systems 19
Unit 19 Mervue Business Park
Mervue Galway
IRELAND
Phone +353 91 746200
wwwchemosatcom
Delcath Systems is a specialty pharmaceutical and medical
device company focused on oncology Our proprietary
product ndash the Delcath Hepatic Delivery System for use with
Melphalan Hydrochloride ndash is designed to administer high-
dose chemotherapy to the liver while controlling systemic
exposure
SILVER
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
64 ECIO ndash European Conference on Interventional Oncology
C RSE
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
65Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
SILVERDFINE Europe GmbH 3
Dynamostr 3
68165 Mannheim
GERMANY
Phone +49 621 8209 00
Fax +49 621 820 905 77
E-Mail infodfineeu
wwwdfineeu
DFINE is a medical device company dedicated to improving
patient quality of life through the development of inno-
vative minimally invasive therapeutic devices used to
treat pathologies of the vertebrae DFINE is the developer
of Radiofrequency-Targeted Vertebral Augmentationtrade
(RF-TVAtrade) also referred to as RF Kyphoplasty a novel
approach to stabilizing vertebral compression fractures
relieving pain and improving patient mobility Performed
with the companys flagship StabiliTreg Vertebral Augmen-
tation System RF -TVAtrade provides physicians with greater
control in the treatment of vertebral compression fractures
through site- and size-specific cavity creation ultra-high
viscosity bone cement with extended working time and a
unique remotely controlled cement delivery system
DFINE recently received 510(k) clearance for the STARtrade
Tumor Ablation System a new product line designed for the
palliative treatment of cancer patients The product provides
minimally invasive localized tumor ablation for symptomatic
spinal metastases offering patients the potential for
significant and immediate pain relief DFINE Europe GmbH is
based in Mannheim Germany
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
66 ECIO ndash European Conference on Interventional Oncology
C RSE
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
67Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Endocare Inc 6
9825 Spectrum Drive Building 3
TX 78717 Austin
UNITED STATES
Phone +1 512 314 4391
E-Mail internationalhealthtronicscom
wwwhealthtronicscom
Endocare Inc is a medical device company focused on the
development of minimally invasive technologies for tissue
and tumor ablation With over 10 years of clinical experience
in percutaneous cryoablation for kidney lung palliative pain
management and other tissues we remain committed to
innovative technology that improves and extends patientsrsquo
lives
Galil Medical 16
4364 Round Lake Road West
MN 55112 Arden Hills
UNITED STATES
Phone +1 877 639 2796
Fax +1 877 510 7757
E-Mail infogalilmedicalcom
wwwgalilmedicalcom
Galil Medical develops manufactures and distributes inno-
vative cryoablation systems and disposable products for
minimally invasive tissue ablation Galil Medical is the only
company solely committed to advancing cryoablation over
a broad range of applications demonstrated by product
and technology innovation physician collaboration new
product introductions and multiple ongoing clinical studies
Stop by the Galil Medical booth to share your insight on
ablative applications and to learn about resources available
to support your interventional oncology practice Galil
Medical is based in Arden Hills Minnesota with operations in
Yokneam Israel
SILVER
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
68 ECIO ndash European Conference on Interventional Oncology
GE Healthcare 8
283 rue de la Miniegravere
78530 Buc
FRANCE
Phone +33 6 28 03 12 71
E-Mail jocelynkartesgecom
wwwgehealthcarecouk
GE Healthcare provides transformational medical technolo-
gies and services to meet the demand for increased access
enhanced quality and more affordable healthcare around
the world GE (NYSE GE) works on things that matter ndash great
people and technologies taking on tough challenges From
medical imaging software amp IT patient monitoring and dia-
gnostics to drug discovery biopharmaceutical manufacturing
technologies and performance improvement solutions GE
Healthcare helps medical professionals deliver great health-
care to their patients For more information visit our website
wwwgehealthcarecouk
Guerbet 12
PO Box 57400
95943 Roissy CdG Cedex
FRANCE
Phone +33 1 45 91 50 00
E-Mail directioncommunicationguerbet-groupcom
wwwguerbetcom
Guerbet is a human-scale company that aims to become
a new global leader in medical imaging A pioneer in con-
trast media with 90 years of experience Guerbet is the
only pharmaceutical group dedicated to medical imaging
worldwide with a presence in almost 80 countries via a
network of subsidiaries and distributors The company offers
a comprehensive range of CT scan Cath Lab Magnetic
Resonance Imaging (MRI) and Interventional Radiology
and Theranostics (IRT) products along with a range of in-
jectors and related medical devices to improve patients
diagnosis prognosis and quality of life More than 60000
health professionals rely on Guerbets contrast agents
Advancing in innovation solutions the diagnosis of major
diseases (cardiovascular diseases cancers diseases of the
central nervous system) and interventional radiology while
SILVER
DIAMOND
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
69Technical Exhibitors Guide
reconciling efficacy and cost containment are at the heart
of Guerbets mission Since the acquisition of Mallinckrodts
Contrast Media and Delivery Systems activity its total
workforce is 2500 employees Achieve Cooperate Care
and Innovate are the values that Guerbets employees share
and practice every day Working at Guerbet means playing
a unique part in the future of medical imaging Passionate
about its business the company strives day in day out to
combine performance quality and sustainable development
Hyprevention 7
PTIB ndash Hopital Xavier Arnozan
Avenue du Haut-Leveque
33604 Pessac
FRANCE
wwwhypreventioncom
Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic
surgeons Hyprevention is a French company that develops
manufactures and sells implantable medical devices to
address unmet clinical needs It is certified ISO 13485
2003 since January 2014 and CMDCAS since January 2015
Hyprevention received CE mark approval for its first product
Y-STRUTreg indicated for percutaneous internal fixation for
impending pathological fracture of proximal femur
Interventional News 4a
526 Fulham Road
SW6 5NR London
UNITED KINGDOM
Phone +44 20 7736 8788
Fax +44 20 7736 8283
E-Mail shilpabibamedicalcom
wwwinterventionalnewscom
Interventional News is a specialised quarterly newspa-
per which goes out to over 12100 subscribers in Europe
and North America Published by BIBA Medical it is an
editorially independent news brand steered by internation-
ally renowned editors-in-chief Professor Andy Adam and
Cardiovascular and Interventional Radiological Society of Europe
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
70 ECIO ndash European Conference on Interventional Oncology
Dr Brian Stainken Interventional News contains the latest
news opinion from thought leaders in interventional radio-
logy summaries of cutting-edge research expert analysis
conference coverage information and updates on the latest
products and the medical device industry Please visit
wwwinterventionalnewscom for regular breaking news
updates and download the IN app for Apple devices from the
app store for live conference coverage Stay in touch with the
latest developments in the world of intervention ndash get your
free subscription to the print copy of Interventional News and
our fortnightly e-newsletters at httpwwwcxvascularcom
publishing-orders
Medtronic 9
Victor Von Bruns-Strasse 19
8212 Neuhausen Am Rheinfall
SWITZERLAND
wwwmedtroniccom
As a global leader in medical technology services and
solutions Medtronic improves the health and lives of millions
of people each year We believe our deep clinical therapeu-
tic and economic expertise can help address the complex
challenges ndash such as rising costs aging populations and the
burden of chronic disease ndash faced by families and health-
care systems today But no one can do it alone Thatrsquos why
wersquore committed to partnering in new ways and developing
powerful solutions that deliver better patient outcomes
Founded in 1949 as a medical repair company were now
among the worlds largest medical technology services and
solutions companies employing more than 85000 people
worldwide serving physicians hospitals and patients in more
than 155 countries Join us in our commitment to take health-
care Further Together Learn more at Medtroniccom
C RSE
DIAMOND
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
71Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Merit Medical 22
Amerikalaan 42
6199 AE Maastricht
NETHERLANDS
E-Mail marketingemeameritcom
wwwmeritemeacom
Merit Medical is a worldwide company engaged in the de-
velopment manufacture and distribution of medical devices
used in interventional oncology procedures Meritrsquos com-
prehensive product portfolio allows you to access diagnose
and treat tumors This portfolio includes radial access pro-
ducts the SwiftNINJAreg steerable microcatheter for delivery
of embolics and the Safeguardtrade closure device In addition
Merit offers the HepaSpheretrade Microspheres embolic (not
available in the United States) which is indicated for emboli-
zation of hepatocellular carcinoma and for liver metastases
HepaSpheretrade Microspheres embolic can be loaded with
Doxorubicin or Irinotecan and is conformable for optimal
occlusion and contact with the vessel wall resulting in need-
ing fewer vials
Mint Medical 4b
Friedrich-Ebert-Straszlige 2
69221 DossenheimHeidelberg
GERMANY
Phone +49 6221 6479 76-1
Fax +49 6221 6479 76-8
E-Mail infomint-medicalde
wwwmint-medicalcom
Mint Medical provides software solutions for standardized
context-driven read procedures and structured reports for
oncologic disease in clinical routine and research
Developed and adapted to the daily needs of oncologic
radio logy Mint Medicalrsquos software solution mint Lesiontrade
focuses on the particular context of a patient case and gen-
tly offers guidance according to the corresponding scree-
ning staging or response assessment criteria mint Lesiontrade
knows about the intricacies of particular guidelines and
GOLD
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
72 ECIO ndash European Conference on Interventional Oncology
C RSE
automatically determines the stage of disease and response
to therapy based on radiological multiparametric image
annotations classifications and further clinical parameters
The profiles include a variety of TNM tumor entities staging
and transplant scoring of liver disease screening and staging
of prostate carcinoma and numerous response evaluation
criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi
RANO PCWG2 etc) In addition mint Lesiontrade characterizes
lesions also by their texture and highlights potential tipping
points for clinical treatment decisions during the read process
and in the automatically generated structured reports
Nanjing ECO Microwave System Co Ltd 20
10F 2nd Building Binjiang Plaza No305
North Jiangdong Rd
Nanjing
CHINA
Phone +86 25 86587596
Fax +86 25 86262777
wwwnjecomedcom
We are a manufacturer in China focused on interventional
oncology We have 14 years of experience with cancer treat-
ment (MWA) since the year 2002 We have also invented the
Water Circulation Cooling System and make MWA and even
RFA treatments available for most patients Now we have
more than 400 MWA installations worldwide including port-
able systems and mobile systems The top model is equipped
with LCD touch-screen self-check function and temperature
monitoring function This will help to make treatments safer
and more effective The application for MWA has been ex-
tended to liver cancer lung cancer thyroid nodules breast
nodules and cancer uterine fibroids bone tumors and kidney
tumors Our antenna can be guided under ultrasound and
CT scan and is also MRI compatible We also hold the China
International Conference for Microwave Tumor Ablation
Treatment each year at Dec 12th in Nanjing China Last
year 400 doctors attended this conference where the latest
research on MWA treatment was shared with visitors
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
73Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
NeuWave Medical 17
3529 Anderson St
WI 53704 Madison
UNITED STATES
Phone +1 877 323 9283
Fax +1 608 512 1509
E-Mail infoneuwavecom
wwwneuwavecom
NeuWave Medicalreg Inc founded by physicians and scientists
created the first Intelligent Ablationtrade system powered by
the Certusreg 140 The unique auto-synchronized system offers
predictable round ablations for any shape or size lesion With
a focus on predictability and simple versatility this total treat-
ment platform provides a truly scalable system that delivers
tailored treatment for patients
NUMA 15
Block 1 Quayside Business Park Mill Street Dundalk
A91 DP8R Co Louth
IRELAND
Phone +353 42 9429502
Fax +353 42 9390220
E-Mail infonumaie
wwwnumaie
Image-guided Minimally Invasive Cancer Treatments (MICTs)
form a rapidly growing field of alternatives to full surgical
resection allowing an interventionalist to perform highly
targeted treatments Prediction of the precise ablation
boundary is crucial to ensure both complete tumour
destruction and the protection of sensitive structures To
assist radiologists in the training and planning for these
interventions two software tools have been developed by
the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT
(wwwclinicimppacteu) projects co-funded by the European
Commissionrsquos FP7 programme The GoSmart software pro-
vides a unified web environment enabling interventionalists
to upload patient scans identify important structures and
SILVER
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
74 ECIO ndash European Conference on Interventional Oncology
C RSE
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
75Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
simulate a range of key MICTs It is highly extensible with
an interface for manufacturers researchers and medical
tech nicians to incorporate new equipment treatment
protocols and theoretical models The RFA-Guardian software
developed in the ClinicIMPPACT project provides a very fast
Radio Frequency Ablation (RFA) simulation environment
that is currently based around the AngioDynamics StarBurst
XL needle and is part of a clinical trial in 4 hospitals across
Europe Its speed and optimised functionality for clinical use
make it very attractive for RFA planning
PharmaCept GmbH 18
Bessemerstraszlige 82
12103 Berlin
GERMANY
Phone +49 30 75 65 985-0
E-Mail infopharmaceptcom
wwwpharmaceptcom
PharmaCept stands for a successful development of niche
products and instructions in the area of cancer treatment
with a special focus on research in Interventional Oncology
The main pillar of our companyrsquos development is in the field
of chemoembolization therapy On the basis of the Barcelona
guidelines for the treatment of primary liver cell carcinoma
chemoembolization has become an integral part of the treat-
ment of this illness Increasing experience has shown that
the use of permanent vascular occlusion materials promotes
the development of new blood vessels which sustain tumor
growth As well as stimulating growth permanent vascular
occlusion also exacerbates pain With EmboCeptreg S our bio-
degradable starch microspheres these side effects can be
considerably reduced New clinical studies will now further
scientifically explore the already known advantages of short-
term vessel-blockage and unlimited combination with drugs
eg our Cisplatin powder named PlatiCeptreg with the use of
our embolizate EmboCeptreg S
GOLD
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
76
C RSE
ECIO ndash European Conference on Interventional Oncology
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
RF Medical Co Ltd 21
503 506 254 Beotkkot-ro
Geumcheon-gu
153-801 Seoul
KOREA
E-Mail overseasrfacokr
wwwrfacokr
As a manufacturer RF Medical is dedicated to popularizing
radiofrequency ablation treatments since 2003 Our extensive
product range spans from tumor ablation to varicose vein
treatments Our sophisticated technology has allowed us
to spread our business to more than 40 countries and our
proven quality has granted us a strong reputation on the
market As always RF Medical strives with all its capabilities
to create a healthier world by continuous investment in
research and development
Siemens Healthcare GmbH 24
Henkestr 127
91052 Erlangen
GERMANY
Phone +49 9131 84-0
Fax +49 9131 84-2924
E-Mail contacthealthcaresiemenscom
wwwhealthcaresiemenscom
Siemens Healthcare is one of the worldrsquos largest suppliers
of technology to the healthcare industry and a leader in
medical imaging laboratory diagnostics and healthcare
IT All supported by a comprehensive portfolio of clinical
consulting training and services available across the globe
and tailored to customersrsquo needs
In fiscal 2014 Siemens Healthcare had around 43000
em ployees worldwide and posted a revenue worth
117 billion euros and profits of more than 2 billion euros
Further information is available on the Internet at
httpwwwhealthcaresiemenscom
SILVER
77Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
DIAMOND
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
78 ECIO ndash European Conference on Interventional Oncology
C RSE
Sirtex Medical Europe GmbH 11
Joseph-Schumpeter-Allee 33
53227 Bonn
GERMANY
Phone +49 228 18407 30
Fax +49 228 18407 35
E-Mail infosirtex-europecom
wwwsirtexcom
Sirtex Medical is actively engaged in the field of liver-directed
therapies for cancer patients The innovative technology of
Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic
Yttrium-90 resin beads) is a medical device used in inter-
ventional oncology to deliver Selective Internal Radiation
Therapy (SIRT) also known as radioembolisation to the liver
This treatment for inoperable liver cancer delivers high doses
of radiation directly to the site of tumours whilst conserving
normal liver parenchyma SIR-Spheresreg microspheres were
approved in 2002 for use in the treatment of a variety of
unresectable liver tumours as well as in hepatocellular carci-
noma within the European Union under a CE Mark They are
presently used at 250+ institutions in Europe and over 55000
doses of SIR-Spheresreg microspheres have been supplied
worldwide
The SIRFLOX study evaluated the efficacy and safety of add-
ing SIR-Spheresreg Y-90 resin microspheres to a current first-
line systemic chemotherapy in patients with non-resectable
colorectal liver metastases SIRFLOX is the largest randomised
interventional radiology study ever conducted in oncology
This study has now been published in the Journal of Clinical
Oncology the most widely read prestigious official journal of
the ASCO
DIAMOND
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
79
Cardiovascular and Interventional Radiological Society of Europe
Technical Exhibitors Guide
STARmed Co Ltd 4
402 Daebang Triplaon B 1681
Jungsan-dong IlsanDong-gu
410315 Goyang-si Gyeonggi-do
KOREA
Phone +82 506 816
E-Mail infostarmed4ucom
wwwstarmed4ucom
STARmed Co Ltd is a young and fast-growing company
from South Korea specializing in radiofrequency tech nology
Passionately working on the best possible RF treatment
STARmed has collaborated with a number of key opinion
leaders in developing the most innovative electrodes and
leading-edge RF technology specific to certain tumour types
and clinical applications in liver lung kidney myoma bone
etc Currently STARmed is proud to be the world leader in
thermal ablation of benign thyroid nodules through radio-
frequency In addition to RampD and manufacturing STARmed
devotes its time and resources to professional education
through master classes hands-on workshops and proctor-
ship for doctors keen on such minimally invasive procedures
STARmed strives to be your best partner in radiofrequency
ablation
Surefire Medical Inc 5
6272 W 91st Avenue
CO 80031 Westminster
UNITED STATES
Phone +1 303 426 1222
Fax +1 303 426 1223
E-Mail infosurefiremedicalcom
wwwsurefiremedicalcom
Surefire Medical Inc based in Westminster Colo was
founded in 2009 to develop innovative infusion systems for
the Interventional Radiology and the Interventional Oncology
markets Surefirersquos technology is designed to precisely deliver
embolic agents through a unique microcatheter with an
expandable tip which collapses during forward flow to allow
normal blood flow to carry therapy as close to the tumor
GOLD
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
80 ECIO ndash European Conference on Interventional Oncology
C RSE
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
81Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
as possible In reverse flow when drugsmicrospheres are
being delivered by the system the tip automatically and
dynamically expands to the vessel wall creating a pressure
gradient that drives the therapeutic agents deeply into the
tumor while blocking backflow that might damage healthy
tissue The Surefire Infusion Systems and Surefire Precision
have received regulatory approval in the US Europe
Canada Australia New Zealand Taiwan Mexico and Brazil
Surgical Specialties Corporation 14
50 Braintree Hill Office Park Suite 101
MA 02184 Braintree
UNITED STATES
Phone +1 781 602 6771
wwwsurgicalspecialtiescom
Surgical Specialities designs and manufactures high per-
formance interventional radiology products surgical knives
and wound closure products At ECIO we are featuring the
BioSentrytrade Tract Sealant System a CE and FDA-approved
device to help prevent Pneumothorax BioSentry is a repeat-
able straight-forward two minute procedure used after a
lung biopsy which has proven protection in clinical trials to
reduce pneumothorax by 50 and chest tube placement
by 67 Please stop by our booth 14 to learn more and
request a demo Surgical Specialties Corporation is a sharp
company driven by sharp dedicated people It has a proven
track record within the field of precision surgical instrument
design and manufacturing that underscores not only its
high engineering standards but also its customer-driven
collaborative values Surgical Specialties Corporation is proud
to provide quality products flexible and accommodating
customer service and value to its customers worldwide
Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung
biopsy tract plug for reduction of postbiopsy pneumothorax and
other complications results of a prospective multicenter randomized
controlled clinical study J Vasc Interv Radiol 2010211235-1243
SILVER
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
ECIO ndash European Conference on Interventional Oncology
Terumo Europe 10
7-9 Rue Eugegravene et Armand Peugeot
92500 Rueil Malmaison
FRANCE
Phone +33 1 47 16 09 46
Fax +33 1 47 16 09 49
E-Mail alexandravassiliadesterumo-europecom
wwwterumo-europecom
Founded in Tokyo in 1921 Terumo is a multinational company
with more than 90 yearsrsquo experience in developing best in
class medical devices Pushing boundaries is what drives us
so that interventionalists can do more Rising to the challenge
of innovating for patients Terumo brings you a complete
range of Interventional Oncology products
Leading edge access and delivery systems (Occlusafereg
Radiofocusreg Guidewire GT Progreatreg Glidecathreg)
Complete range of embolic devices (AZURreg Peripheral
HydroCoilreg AZURreg CX HydroPearlreg)
Ablation systems (MicroThermXreg)
Easily visible Radioembolics (manufactured by Quirem)
Drug-eluting Microspheres (LifePearlreg)
Having pioneered the field of Interventional Oncology
Terumo is relentlessly seeking new ways to help you apply
effective solutions and achieve better outcomes We are
committed to support our comprehensive product portfolio
by a well-trained field force and a solid clinical evidence
DIAMOND
C RSE
82
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
83Technical Exhibitors Guide
Cardiovascular and Interventional Radiological Society of Europe
Toshiba Medical Systems Europe 23
Zilverstraat 1
2718RP Zoetermeer
NETHERLANDS
Phone +31 79 3689 222
wwwtoshiba-medicaleu
For over 140 years Toshibarsquos research and development has
improved the health and welfare of people around the world
Today Toshiba Medical Systems offers a full range of dia-
gnostic imaging products and is a reliable service partner
in more than 135 countries around the globe Our Mission is
to deliver the best quality products and services as well as
the industryrsquos best after-sales support through long-term
customer focused partnerships
Wisepress Medical Bookshop 25
25 High Path
Merton Abbey
SW19 2JL London
UNITED KINGDOM
Phone +44 20 8715 1812
Fax +44 20 8715 1722
E-Mail marketingwisepresscom
wwwwisepresscom
Wisepresscom Europersquos leading conference bookseller
has a range of books and journals relevant to the themes of
the meeting In addition to attending 200 conferences per
year Wisepress has a comprehensive medical and scientific
bookshop online with great offers Follow us on Twitter for
the latest news WisepressBooks
GOLD
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
C RSE
ECIO ndash European Conference on Interventional Oncology84
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
8585Notes
Cardiovascular and Interventional Radiological Society of Europe
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint
86 ECIO ndash European Conference on Interventional Oncology
CIRSE Central Office
Neutorgasse 9
1010 Vienna Austria
Phone +43 1 904 2003
Fax +43 1 904 2003 30
E-mail infocirseorg
Web wwwecioorg
The ECIO 2016 Pocket Guide
In case of any queries or comments
please contact us at infocirseorg
copy Cardiovascular and Interventional Radiological Society of
Europe 2016
GraphX by L O O P E N T E R P R I S E S media
wwwloop-enterprisescom
Imprint